Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lauren Albertine

Nurse Practitioner, Family Germantown, TN Nurse Practitioner

NPI 1073087490 CMS profile 10821492

7945 Wolf River Blvd, Germantown, TN 38138

Open in the dashboard

General payments

$8,187

383 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lauren Albertine of Germantown, TN is reported in the CMS Open Payments database as having received $8,187 across 383 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,576 70
2024 General $2,059 101
2023 General $1,757 81
2022 General $1,214 67
2021 General $1,581 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauren Albertine
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Lauren Albertine were reported at $1,576. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Lauren Albertine Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $1,581 $124 $35–$379 $132
2022 $1,214 $141 $44–$430 $149
2023 $1,757 $154 $49–$476 $160
2024 $2,059 $165 $51–$504 $164
2025 $1,576 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $1,286 64 payments
  2. Lilly USA, LLC $435 25 payments
  3. Janssen Biotech, Inc. $411 25 payments
  4. E.R. Squibb & Sons, L.L.C. $349 10 payments
  5. Pfizer Inc. $338 19 payments
  6. Seattle Genetics, Inc. $326 19 payments
  7. AstraZeneca Pharmaceuticals LP $284 14 payments
  8. Merck Sharp & Dohme Corporation $274 16 payments
  9. Novartis Pharmaceuticals Corporation $271 14 payments
  10. Astellas Pharma US Inc $247 8 payments
  11. Other $3,968 169 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,823 379 payments
  2. Education $364 4 payments
Products named General payments · program years 2021–2025
  1. Diamondback Peripheral $382 16 payments
  2. OPDIVO $326 9 payments
  3. XPOVIO $226 2 payments
  4. KEYTRUDA $220 12 payments
  5. ESPRIT $219 10 payments
  6. JAYPIRCA $213 11 payments
  7. Lenvima $208 6 payments
  8. Trodelvy $204 9 payments
  9. VERZENIO $204 11 payments
  10. ERLEADA $199 11 payments
  11. Other $6,383 337 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

263

Median for Nurse Practitioner: 389

Drug cost

$22,102

Median for Nurse Practitioner: $21,885

Branded share of claims

18.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 25 $18,805
Anastrozole Generic 56 $701
Tamoxifen Citrate Generic 24 $553
Letrozole Generic 22 $374
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $330
Ondansetron Odt Ondansetron Brand 11 $297
Gabapentin Generic 28 $252
Hydrocortisone Generic 12 $197
Oxybutynin Chloride Generic 21 $154
Potassium Chloride Generic 14 $153

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$174,103

Of which drugs: $117,667

Medicare patients

582

Average age 74

Services billed

9,749

385 women, 197 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 73%
Arthritis 47%
Diabetes 35%
Ischemic heart disease 34%
Chronic kidney disease 33%
Heart failure 21%
Depression 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 11 190 $18

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 40 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ORGOVYX
  • Sumitomo Pharma America, Inc. $58
  • PFIZER INC. $20
$77 — —
JAYPIRCA
  • Lilly USA, LLC $72
$72 — —
VERZENIO
  • Lilly USA, LLC $72
$72 — —
ENHERTU
  • Daiichi Sankyo Inc. $40
  • AstraZeneca Pharmaceuticals LP $30
$70 — —
Padcev
  • PFIZER INC. $49
  • Astellas Pharma US Inc $18
$67 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 40 with Patron

Records

383 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record